Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
0.9004
+0.0020 (0.22%)
Oct 30, 2026, 11:23 AM EDT - Market open
Coherus Oncology Market Cap
Coherus Oncology has a market cap or net worth of $139.11 million as of October 30, 2026. It is the 22,884th most valuable company in the world and the 3,864th biggest in the United States. Its market cap has decreased by 30.81% in one year.
Market Cap
139.11M
Enterprise Value
87.98M
1-Year Change
-30.81%
Global Rank
Country Rank
#3,864 United States
Category
ChartMarket Cap Chart
Since November 6, 2014, Coherus Oncology's market cap has decreased from $404.18M to $139.11M, a decrease of -65.58%. That is a compound annual growth rate of -8.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 139.11M | -18.95% |
| Dec 31, 2025 | 171.64M | 7.95% |
| Dec 31, 2024 | 158.99M | -57.13% |
| Dec 29, 2023 | 370.84M | -52.31% |
| Dec 30, 2022 | 777.58M | -36.55% |
| Dec 31, 2021 | 1.23B | -2.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atrium Therapeutics | 144.20M |
| Compass Therapeutics | 143.62M |
| Veraxa Biotech AG | 142.11M |
| NovaBridge Biosciences | 141.52M |
| Satellos Bioscience | 140.49M |
| Spruce Biosciences | 139.39M |
| Codexis | 139.07M |
| Molecular Partners AG | 137.98M |